Published in J Cell Biol on February 21, 2011
Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med (2012) 2.39
Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci (2014) 1.15
Tau phosphorylation affects its axonal transport and degradation. Neurobiol Aging (2013) 1.00
NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss. Cell Death Dis (2013) 0.98
Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost (2013) 0.92
Physiological and pathological phosphorylation of tau by Cdk5. Front Mol Neurosci (2014) 0.91
Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons. Mol Biol Cell (2014) 0.91
Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms. Biochemistry (2011) 0.90
Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats. Biophys J (2014) 0.89
Microglia: an active player in the regulation of synaptic activity. Neural Plast (2013) 0.88
Rapid changes in phospho-MAP/tau epitopes during neuronal stress: cofilin-actin rods primarily recruit microtubule binding domain epitopes. PLoS One (2011) 0.83
FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions. Biochemistry (2012) 0.82
Interplay between phosphorylation and palmitoylation mediates plasma membrane targeting and sorting of GAP43. Mol Biol Cell (2014) 0.81
Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule-binding repeats in filament nucleation. Protein Sci (2013) 0.81
Extracellular α-synuclein leads to microtubule destabilization via GSK-3β-dependent Tau phosphorylation in PC12 cells. PLoS One (2014) 0.80
Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes. Mol Neurodegener (2015) 0.80
Roles of tau protein in health and disease. Acta Neuropathol (2017) 0.80
RNA protein granules modulate tau isoform expression and induce neuronal sprouting. J Biol Chem (2014) 0.79
Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases? Cell Mol Life Sci (2015) 0.78
Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain. J Alzheimers Dis (2015) 0.78
Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model. Mol Neurodegener (2016) 0.78
A refined reaction-diffusion model of tau-microtubule dynamics and its application in FDAP analysis. Biophys J (2014) 0.77
An evolutionary roadmap to the microtubule-associated protein MAP Tau. BMC Genomics (2016) 0.77
Tau Biology and Tau-Directed Therapies for Alzheimer's Disease. Drugs (2016) 0.77
Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain. BMC Neurosci (2014) 0.77
Tau physiology and pathomechanisms in frontotemporal lobar degeneration. J Neurochem (2016) 0.76
Derailed intraneuronal signalling drives pathogenesis in sporadic and familial Alzheimer's disease. Biomed Res Int (2014) 0.76
Optical highlighter molecules in neurobiology. Curr Opin Neurobiol (2011) 0.76
Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein. Sci Rep (2017) 0.76
Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau. Sci Rep (2016) 0.76
Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations. Front Aging Neurosci (2015) 0.75
Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells. Microb Cell (2016) 0.75
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease. Alzheimers Dement (2016) 0.75
Presence of a carboxy-terminal pseudorepeat and disease-like pseudohyperphosphorylation critically influence tau's interaction with microtubules in axon-like processes. Mol Biol Cell (2016) 0.75
Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants. Sci Rep (2016) 0.75
A photoactivatable GFP for selective photolabeling of proteins and cells. Science (2002) 12.02
Annexins: from structure to function. Physiol Rev (2002) 6.78
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol (1987) 5.92
Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol (2005) 5.71
Analysis of binding reactions by fluorescence recovery after photobleaching. Biophys J (2004) 5.12
Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci U S A (2004) 3.78
Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci (2008) 3.19
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron (1993) 2.84
Annexins--unique membrane binding proteins with diverse functions. J Cell Sci (2004) 2.74
beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron (1995) 2.56
Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol (1995) 2.29
Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta (2005) 1.95
Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann Neurol (1997) 1.94
High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet (1999) 1.87
Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem (2003) 1.86
Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med (2004) 1.76
Global hairpin folding of tau in solution. Biochemistry (2006) 1.69
Annexins and membrane dynamics. Biochim Biophys Acta (1997) 1.56
The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J Cell Sci (1992) 1.48
Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J Neurosci (2004) 1.46
Expression of annexins as a function of cellular growth state. J Cell Biol (1990) 1.42
Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J Neurosci (2009) 1.40
Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell (2000) 1.39
Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol (1996) 1.39
Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett (1999) 1.36
Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci (2002) 1.31
Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau. J Biol Chem (2007) 1.24
Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem (2001) 1.24
Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem (2000) 1.22
Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res (2000) 1.21
Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells. J Cell Biol (1988) 1.17
Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur J Neurol (2008) 1.11
FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells. J Biol Chem (2006) 1.08
Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau. Am J Pathol (2002) 1.04
Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. Am J Pathol (2001) 1.02
Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem J (2001) 1.00
Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am J Pathol (1999) 0.99
Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. J Biol Chem (2003) 0.98
The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord (2004) 0.97
Annexin gene structures and molecular evolutionary genetics. Cell Mol Life Sci (1997) 0.97
Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding. J Biol Chem (2010) 0.96
Microtubule binding and trapping at the tip of neurites regulate tau motion in living neurons. Traffic (2009) 0.96
Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps. J Neurochem (2008) 0.96
Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dement Geriatr Cogn Disord (2008) 0.92
Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am J Pathol (1994) 0.92
Increases in p11 and annexin II proteins correlate with differentiation in the PC12 pheochromocytoma. Biochem Biophys Res Commun (1991) 0.83
Comparative genetic and physiological studies of the MAP kinase Mpk1p from Kluyveromyces lactis and Saccharomyces cerevisiae. J Mol Biol (2000) 0.81
Frontotemporal dementia and tauopathy. Curr Neurol Neurosci Rep (2001) 0.79
Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 45.19
Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature (2011) 8.29
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol (2007) 6.56
PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell (2007) 5.84
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol (2011) 4.83
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature (2012) 4.08
Annexins--unique membrane binding proteins with diverse functions. J Cell Sci (2004) 2.74
Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell (2009) 2.39
Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J (2005) 2.25
Posttranscriptional expression regulation: what determines translation rates? PLoS Comput Biol (2007) 2.09
Functional expression of the epithelial Ca(2+) channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex. EMBO J (2003) 1.97
Requirement for annexin A1 in plasma membrane repair. J Biol Chem (2006) 1.90
Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem (2003) 1.86
Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood (2004) 1.85
Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J (2007) 1.81
MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood (2004) 1.71
Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate binding protein recruited to actin assembly sites at cellular membranes. J Cell Sci (2004) 1.65
Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci (2002) 1.52
Annexin-actin interactions. Traffic (2004) 1.51
Retinosomes: new insights into intracellular managing of hydrophobic substances in lipid bodies. J Cell Biol (2004) 1.45
S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res (2004) 1.41
Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J Neurosci (2009) 1.40
Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol (2010) 1.38
MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. J Biol Chem (2003) 1.37
Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol Biol Cell (2005) 1.32
Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling. Mol Cell Proteomics (2006) 1.32
Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci (2002) 1.31
Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion. J Cell Sci (2008) 1.30
Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol (2011) 1.29
S100A10/p11: family, friends and functions. Pflugers Arch (2007) 1.28
The annexin 2/S100A10 complex controls the distribution of transferrin receptor-containing recycling endosomes. Mol Biol Cell (2003) 1.27
An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol (2004) 1.25
Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells. EMBO J (2004) 1.25
Cell-surface attachment of pedestal-forming enteropathogenic E. coli induces a clustering of raft components and a recruitment of annexin 2. J Cell Sci (2002) 1.21
A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation. Nat Chem Biol (2012) 1.13
The Rab GTPase Ypt7 is linked to retromer-mediated receptor recycling and fusion at the yeast late endosome. J Cell Sci (2010) 1.13
Wnt signaling regulates transendothelial migration of monocytes. J Leukoc Biol (2006) 1.12
Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior. J Neurosci (2006) 1.11
S100A2 induces metastasis in non-small cell lung cancer. Clin Cancer Res (2009) 1.09
aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formation. J Cell Biol (2012) 1.07
Cooperative adsorption of ezrin on PIP2-containing membranes. Biochemistry (2006) 1.05
Endothelial Rho signaling is required for monocyte transendothelial migration. FEBS Lett (2002) 1.05
Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis. J Biol Chem (2007) 1.05
Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest (2012) 1.05
Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P. Mol Biol Cell (2003) 1.04
The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol (2004) 1.04
Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease. FASEB J (2007) 1.04
Cell-cell junctions of dermal microvascular endothelial cells contain tight and adherens junction proteins in spatial proximity. Biochemistry (2004) 1.04
The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains. ACS Chem Biol (2013) 1.04
Annexin A8 regulates late endosome organization and function. Mol Biol Cell (2008) 1.03
O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J Biol Chem (2005) 1.03
Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol (2002) 1.02
The yeast Wsc1 cell surface sensor behaves like a nanospring in vivo. Nat Chem Biol (2009) 1.01
Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor. J Med Chem (2013) 1.00
Chemical proteomic analysis reveals the drugability of the kinome of Trypanosoma brucei. ACS Chem Biol (2012) 1.00
Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol (2013) 0.99
TRPV5 is internalized via clathrin-dependent endocytosis to enter a Ca2+-controlled recycling pathway. J Biol Chem (2007) 0.99
A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet (2007) 0.99
Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J Neurosci (2005) 0.99
Annexin II is required for apical transport in polarized epithelial cells. J Biol Chem (2003) 0.99
High-resolution imaging of chemical and biological sites on living cells using peak force tapping atomic force microscopy. Langmuir (2012) 0.98
Lipid segregation and membrane budding induced by the peripheral membrane binding protein annexin A2. J Biol Chem (2013) 0.97
Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells. Blood (2008) 0.97
Microtubule binding and trapping at the tip of neurites regulate tau motion in living neurons. Traffic (2009) 0.96
Functional analyses of the extra- and intracellular domains of the yeast cell wall integrity sensors Mid2 and Wsc1. FEBS Lett (2007) 0.95
Together we are strong--cell wall integrity sensors in yeasts. Yeast (2010) 0.95
The formation of the cAMP/protein kinase A-dependent annexin 2-S100A10 complex with cystic fibrosis conductance regulator protein (CFTR) regulates CFTR channel function. Mol Biol Cell (2007) 0.95
Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol (2007) 0.95
Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol (2004) 0.95
The annexin 2-S100A10 complex and its association with TRPV6 is regulated by cAMP/PKA/CnA in airway and gut epithelia. Cell Calcium (2008) 0.95
Release pattern of cardiac biomarkers in left ventricular apical ballooning. Int J Cardiol (2007) 0.94
Chemoproteomic approaches to drug target identification and drug profiling. Bioorg Med Chem (2011) 0.94
Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. Mol Cell Proteomics (2008) 0.94
Phosphatidylserine membrane domain clustering induced by annexin A2/S100A10 heterotetramer. Biochemistry (2005) 0.94
VAMP3 is associated with endothelial weibel-palade bodies and participates in their Ca(2+)-dependent exocytosis. Biochim Biophys Acta (2010) 0.94
Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro. Neurobiol Aging (2010) 0.93
Myosin Va acts in concert with Rab27a and MyRIP to regulate acute von-Willebrand factor release from endothelial cells. Traffic (2011) 0.93
The PSGL-1-L-selectin signaling complex regulates neutrophil adhesion under flow. J Exp Med (2013) 0.93
Cyk3 acts in actomyosin ring independent cytokinesis by recruiting Inn1 to the yeast bud neck. Mol Genet Genomics (2009) 0.93
Rho5p downregulates the yeast cell integrity pathway. J Cell Sci (2002) 0.93
Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration. J Biol Chem (2008) 0.92
Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates. J Biol Chem (2012) 0.92
Measuring cell wall thickness in living yeast cells using single molecular rulers. ACS Nano (2010) 0.91
Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics. BMC Cancer (2012) 0.91
Expression and functions of annexins in the kidney. Am J Physiol Renal Physiol (2005) 0.91
Specific association of annexin 1 with plasma membrane-resident and internalized EGF receptors mediated through the protein core domain. FEBS Lett (2004) 0.91
Identification of an AHNAK binding motif specific for the Annexin2/S100A10 tetramer. J Biol Chem (2006) 0.91
Actin binding of ezrin is activated by specific recognition of PIP2-functionalized lipid bilayers. Biochemistry (2008) 0.91
Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling. EMBO Mol Med (2011) 0.91
Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling. Mol Biol Cell (2013) 0.90
Activation of F-actin binding capacity of ezrin: synergism of PIP₂ interaction and phosphorylation. Biophys J (2011) 0.89
S100P is a novel interaction partner and regulator of IQGAP1. J Biol Chem (2010) 0.89
Annexin A1 is a new functional linker between actin filaments and phagosomes during phagocytosis. J Cell Sci (2011) 0.89